Coldstream Capital Management Inc Vertex Pharmaceuticals Inc Transaction History

Coldstream Capital Management Inc

$4.58 Billion
Q3 2024

A detailed history of Coldstream Capital Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Coldstream Capital Management Inc holds 4,774 shares of VRTX stock, worth $1.95 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,774

Previous 4,222 13.07%

Holding current value

$1.95 Million

Previous $1.98 Million 12.23%

% of portfolio

0.05%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$460.0 - $505.78 $253,920 - $279,190	552 Added 13.07%	4,774 $2.22 Million
Q2 2024 Aug 07, 2024	BUY	$392.81 - $485.53 $99,380 - $122,839	253 Added 6.37%	4,222 $1.98 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $15,492 - $16,951	38 Added 0.97%	3,969 $1.66 Million
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $79,233 - $94,867	231 Added 6.24%	3,931 $1.6 Million
Q3 2023 Nov 02, 2023	BUY	$338.18 - $362.46 $29,083 - $31,171	86 Added 2.38%	3,700 $1.29 Million
Q2 2023 Aug 03, 2023	BUY	$314.42 - $351.91 $12,576 - $14,076	40 Added 1.12%	3,614 $1.27 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $59,195 - $67,527	209 Added 6.21%	3,574 $1.13 Million
Q4 2022 Jan 10, 2023	BUY	$285.76 - $321.48 $75,726 - $85,192	265 Added 8.55%	3,365 $0
Q2 2022 Aug 08, 2022	SELL	$234.96 - $292.55 $203,005 - $252,763	-864 Reduced 32.89%	1,763 $497,000
Q2 2022 Aug 08, 2022	BUY	$234.96 - $292.55 $314,141 - $391,139	1,337 Added 75.84%	3,100 $874,000
Q1 2022 May 11, 2022	BUY	$221.42 - $260.97 $12,842 - $15,136	58 Added 2.26%	2,627 $686,000
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $214,536 - $270,821	1,212 Added 89.31%	2,569 $564,000
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $47,161 - $52,777	260 Added 23.7%	1,357 $369,000
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $5,249 - $6,190	28 Added 2.62%	1,097 $221,000
Q1 2021 Jun 16, 2021	SELL	$207.02 - $241.31 $57,965 - $67,566	-280 Reduced 20.76%	1,069 $230,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $44,507 - $59,359	215 Added 18.96%	1,349 $319,000
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $1,278 - $1,515	5 Added 0.44%	1,134 $308,000
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $4,509 - $5,916	20 Added 1.8%	1,129 $327,000
Q1 2020 May 27, 2020	BUY	$199.77 - $247.81 $31,763 - $39,401	159 Added 16.74%	1,109 $263,000
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $158,374 - $212,714	950 New	950 $208,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Account

Coldstream Capital Management Inc Vertex Pharmaceuticals Inc Transaction History